IgA nephropathy is the most common autoimmune nephropathy which have high incidence rate and even appear renal failure. With the continuous development of network pharmacology, the characteristic with“Drug-active ingredient-disease” has been used in the treatment of IgA nephropathy. Making the characteristic which use TCM, the combination of TCM, medicine made of two or more ingredients to treatment IgA nephropathy in multi-component, multi-target, multi-pathway therapy and network pharmacology together. We found biological activity ingredient which can treat IgA nephropathy, that is quercetin, luteolin and kaempferol. They restrain producing inflammation cytokine which mainly inhibit PI3K/Akt and Akt through the synergistic action of the drug. They decrease immune complex’s sedimentation on lomerulus mesangial cell to reduce inflammation. The combine of TCM and network pharmacology open up a new idea which can remedy IgA nephropathy.

Yun Jiayi, Zhang Yuxin, Zhao Fei. Advances in network pharmacology-based Chinese medicine for the treatment of IgA nephropathy. International Journal of Frontiers in Medicine (2022), Vol. 4, Issue 11: 7-13. https://doi.org/10.25236/IJFM.2022.041102.

[1] Lai, K. N., Tang, S. C., Schena, F. P., et al. IgA nephropathy [J]. Nature reviews. Disease primers, 2016, 2, 16001.

[2] D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors [J]. American journal of kidney diseases: the official journal of the National Kidney Foundation, 2000, 36(2), 227–237. 

[3] Rodrigues, J. C., Haas, M. and Reich, H. N. IgA Nephropathy [J]. Clinical journal of the American Society of Nephrology: CJASN, 2017, 12(4), 677–686. 

[4] Zeng H, Wang L, Li J, et al. Single-cell RNA-sequencing reveals distinct immune cell subsets and signaling pathways in IgA nephropathy[J]. Cell Biosci. 2021 Dec 11; 11(1):203. 

[5] Floege, J. and Feehally, J. The mucosa-kidney axis in IgA nephropathy [J]. Nature reviews. Nephrology, 2016, 12(3), 147–156.

[6] Shen Jiachen, Ren Yi, Rao Xianrong, et al. Molecular mechanism of Andrographis paniculata in the treatment of IgA nephropathy based on network pharmacology, molecular docking and in vitro experiments[J]. World Journal of Integrated Chinese and Western Medicine, 2021, 16(12):2246-2254.

[7] Pang Shuang, Zhao Shuan, Xu Xialian,et al. Analysis of the mechanism of action of Astragalus membranaceus in the treatment of IgA nephropathy based on network pharmacology and in vitro cellular assays[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2021, 27(15):139-147.

[8] Wang, E. M., Fan, Q. L., Yue, Y. ,et al. Ursolic Acid Attenuates High Glucose-Mediated Mesangial Cell Injury by Inhibiting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Signaling Pathway[J]. Medical science monitor: international medical journal of experimental and clinical research, 2018, 24, 846–854.

[9] Zhao Ya, Feng Hui, Zhou Zhen, et al. New drug discovery ideas for the prevention and treatment of diabetic nephropathy based on the "holistic view" of Tibetan medicine[J]. Chinese Journal of Experimental Prescriptions, 2019, 25(3): 167-172.

[10] Lu Xinxing, Fan Qiuling, Xu Li,et al. Ursolic acid attenuates diabetic mesangial cell injury through the upregulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression[J]. PloS one, 2015, 10(2), e0117400.

[11] Pang Xingxing, Xing Yufeng., Peng Zining, et al. Investigation of the mechanism of action of red peony in the treatment of IgAN based on network pharmacology and GEO data analysis [J]. Journal of Translational Medicine, 2021, 10(2):7.

[12] Xu Xingxin, Qi Xiangming, Zhang Wei, et al. Effects of total glucosides of paeony on immune regulatory toll-like receptors TLR2 and 4 in the kidney from diabetic rats[J]. Phytomedicine: international journal of phytotherapy and phytopharmacology, 2014, 21(6), 815–823.

[13] Lu Xiangyang, He Xiaoxie, Liu Yongle, et al. Effect of catechins on the proliferation of thylakoid cells in rats with nephrotic syndrome [J]. Food Science, 2003, (7): 120- 124.

[14] Biswas P. S. IL-17 in Renal Immunity and Autoimmunity [J]. Journal of immunology (Baltimore, Md.: 1950), 2018, 201(11), 3153–3159.

[15] Lin J.R. and Fan J.M. Study on the role of interleukin 17 in causing abnormal IgA1 glycosylation in IgA nephropathy [J]. Chongqing Medicine, 2016, 45 (28): 3907-3909.

[16] Li Hongyan, Guo Yuqin and Ma Xiaoyan. Network-based pharmacology to explore the mechanism of action of B. alba in the treatment of immunoglobulin A nephropathy [J]. Clinical Research in Traditional Chinese Medicine, 2021(013-034).

[17] Zhang Peng, Zhao Qitao, Yang Peimin, et al. Experimental study on the in vitro antitumour effect of nucleoside from C. alba[J]. Lishizhen Medicine and Materia Medica Research, 2012, 23(08):1901-1902.

[18] Wang Xin, Ma Chuanjiang, Yang Peimin, et al. Research progress on the anti-inflammatory and antitumour effects of C. alba[J]. Chinese Modern Applied Pharmacology, 2020, 37(19):2420-2427.

[19] Deng Yanfang and Diao Juanjuan. The application of Baihua Shejiao in common renal diseases in pediatric patients [J]. Hunan Journal of Traditional Chinese Medicine, 2015, 31(3):141-142.

[20] Wang Rumeng, Zhao Mingming, Chang Meiying, et al. A network pharmacological study on the mechanism of action of honeysuckle in the treatment of IgA nephropathy based on pharyngeal and kidney-related theories [J]. World Journal of Integrated Chinese and Western Medicine, 2021, 16(4):8.

[21] Yao Yuanzhang, Zhang Min and Cao Peng. Effects of clearing heat and detoxifying Chinese medicine on TNF-α-induced NF-κB signaling pathway in mouse glomerular thylakoid cells [J]. Chinese Journal of Integrated Chinese and Western Medicine and Nephrology, 2013, 14(12): 1047 - 1050.

[22] Yang Hu, Song Yan, Liang Yanan, et al. Quercetin Treatment Improves Renal Function and Protects the Kidney in a Rat Model of Adenine-Induced Chronic Kidney Disease [J]. Medical science monitor: international medical journal of experimental and clinical research, 2018, 24, 4760–4766.

[23] Liu Xianghua,Sun Ning, Mo Nan, et al. Quercetin inhibits kidney fibrosis and the epithelial to mesenchymal transition of the renal tubular system involving suppression of the Sonic Hedgehog signaling pathway[J]. Food and function, 2019, 10(6), 3782–3797.

[24] Liu, Yanfei, Liu, Yue, Zhang Wantong, et al. Network Pharmacology-Based Strategy to Investigate the Pharmacological Mechanisms of Ginkgo biloba Extract for Aging[J]. Evidence-based complementary and alternative medicine: eCAM, 2020, 8508491.

[25] Lee, J. K., Kim, S. Y., Kim, Y. S.,et al. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin[J]. Biochemical pharmacology, 2009, 77(8), 1391–1400.

[26] Imran, M., Rauf, A., Shah, Z.A., et al. Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review [J]. Phytotherapy research: PTR, 2019, 33(2), 263–275.

[27] Bai Yawen and Ma Chunjie. Network-based pharmacology to explore the mechanism of action of jingyinhua-lianqi medicine on intervention of IgA nephropathy [J]. Modern Drugs and Clinics, 2022(037-002).

[28] Wang Sihai, Fang Zhaohui, NI Yingqun, et al. Effects of Danchuang hypoglycemic capsules on renal TGF-β1/Smad3 signaling pathway and AGEs/RAGE levels in rats with diabetic nephropathy [J]. Chinese Journal of Traditional Chinese Medicine, 2021, 36(4): 2019- 2024.

[29] Cao Li, E Jing, Li Jing,et al. Relationship between IL-21 and IL-17 expression in IgA nephropathy and TNF-α and TGF-β and pathological classification[J]. Ningxia Medical Journal, 2021, 43(3): 196-199.

[30] Liu Huaxi, Lu Zhihao, Tian Chunyang,et al. Network-based pharmacology to explore the mechanism of action of Jun Jun medicine medicine in the treatment of IgA nephropathy hematuria[J]. Journal of Shenyang Pharmaceutical University, 2020(4):10.

[31] Liu L. Study on the role of cyclooxygenase-2-media- ted dysfunction of LDL receptor expression in podo- cyte injury in early stage of diabetic nephropath [D]. Nanjing: Southeast University, 2017.

[32] Nie L H. Effects of Manshen Kangning on renal tissue of renal interstitial fibrosis rats and the regulation of SIRT1/COX-2 expression [D]. Guangzhou: Jinan University, 2013.

[33] Tamouza, H., Chemouny, J. M., Raskova Kafkova, L., et al. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy[J]. Kidney international, 2012, 82(12), 1284–1296.

[34] LI X L. Correlation between serum interleukin-17,vascular endothelial growth factor and renal functionindexes in patients with primary IgA nephropathy[J]. Journal of Clinical Medicine in Practice,2017,21(17): 92－95.

[35] Wang Ailin, Liu Lichang, Liu Xusheng, et al. Network pharmacological mechanism of the formula for the treatment of IgA nephropathy[J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2022(039-002).

[36] Li Ming, Li Liang, Li Weinan ,et al. A network pharmacological study on the mechanism of action of Ginseng-Dihuang Tang in the treatment of IgA nephropathy[J]. China Medicine Herald, 2021, 18(29):8.

[37] Zhang Yuanyuan, Jin Peipei, Gu Yue, et al. Molecular docking and experimental validation based on network pharmacology to explore the mechanism of action of Jiawei Lifting San in the treatment of IgA nephropathy [J]. Chinese Journal of Experimental Formulary.

[38] Ma Sijia, Zhao Mingming, Chang Meiying,et al. Study on the mechanism of action of huangqi qifeng tang with added flavour in the treatment of IgA nephropathy based on network pharmacology method[J]. China Medicine Herald, 2021, 18(17):8.

[39] Ma Jin, Li Zhenwan, Luo Yuezhong, et al. Network-based pharmacological techniques to study the molecular targets of Tao Hong Si Wu Tang in retarding fibroblast growth[J]. China Journal of Chinese Materia Medica, 2020, 45(17):4120-4128.